162 related articles for article (PubMed ID: 29509906)
1. Reduced Levels of Anti-Ageing Hormone Klotho Predict Renal Function Decline in Type 2 Diabetes.
Fountoulakis N; Maltese G; Gnudi L; Karalliedde J
J Clin Endocrinol Metab; 2018 May; 103(5):2026-2032. PubMed ID: 29509906
[TBL] [Abstract][Full Text] [Related]
2. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
[TBL] [Abstract][Full Text] [Related]
3. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
[TBL] [Abstract][Full Text] [Related]
4. Decreased plasma α-Klotho predict progression of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Lee EY; Lee SM; Chung CH; Kwak IS; Lee EK; Kim YK
J Diabetes Complications; 2016 Jul; 30(5):887-92. PubMed ID: 27037042
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
[TBL] [Abstract][Full Text] [Related]
6. Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy.
van Ark J; Hammes HP; van Dijk MC; Lexis CP; van der Horst IC; Zeebregts CJ; Vervloet MG; Wolffenbuttel BH; van Goor H; Hillebrands JL
Cardiovasc Diabetol; 2013 Aug; 12():116. PubMed ID: 23945089
[TBL] [Abstract][Full Text] [Related]
7. Low serum bilirubin level predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus.
Ahn KH; Kim SS; Kim WJ; Kim JH; Nam YJ; Park SB; Jeon YK; Kim BH; Kim IJ; Kim YK
Korean J Intern Med; 2017 Sep; 32(5):875-882. PubMed ID: 28560862
[TBL] [Abstract][Full Text] [Related]
8. Association of plasma soluble α-klotho with pro-endothelin-1 in patients with type 2 diabetes.
Liu JJ; Liu S; Morgenthaler NG; Wong MDS; Tavintharan S; Sum CF; Lim SC
Atherosclerosis; 2014 Apr; 233(2):415-418. PubMed ID: 24530772
[TBL] [Abstract][Full Text] [Related]
9. Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy.
Farías-Basulto A; Martínez-Ramírez HR; Gómez-García EF; Cueto-Manzano AM; Cortés-Sanabria L; Hernández-Ramos LE; Ramírez-López G; Mendoza-Carrera F
Arch Med Res; 2018 Oct; 49(7):451-455. PubMed ID: 30718148
[TBL] [Abstract][Full Text] [Related]
10. Low levels of circulating anti-ageing hormone Klotho predict the onset and progression of diabetic retinopathy.
Corcillo A; Fountoulakis N; Sohal A; Farrow F; Ayis S; Karalliedde J
Diab Vasc Dis Res; 2020; 17(6):1479164120970901. PubMed ID: 33225726
[TBL] [Abstract][Full Text] [Related]
11. Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria.
Lee CH; Hui EY; Woo YC; Yeung CY; Chow WS; Yuen MM; Fong CH; Xu A; Lam KS
J Clin Endocrinol Metab; 2015 Apr; 100(4):1368-75. PubMed ID: 25625802
[TBL] [Abstract][Full Text] [Related]
12. Urinary Potassium Excretion and Renal and Cardiovascular Complications in Patients with Type 2 Diabetes and Normal Renal Function.
Araki S; Haneda M; Koya D; Kondo K; Tanaka S; Arima H; Kume S; Nakazawa J; Chin-Kanasaki M; Ugi S; Kawai H; Araki H; Uzu T; Maegawa H
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2152-8. PubMed ID: 26563378
[TBL] [Abstract][Full Text] [Related]
13. Soluble Klotho and intact fibroblast growth factor 23 in long-term kidney transplant patients.
Bleskestad IH; Thorsen IS; Jonsson G; Skadberg Ø; Bergrem H; Gøransson LG
Eur J Endocrinol; 2015 Apr; 172(4):343-50. PubMed ID: 25572388
[TBL] [Abstract][Full Text] [Related]
14. Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease.
Seiler S; Wen M; Roth HJ; Fehrenz M; Flügge F; Herath E; Weihrauch A; Fliser D; Heine GH
Kidney Int; 2013 Jan; 83(1):121-8. PubMed ID: 22895520
[TBL] [Abstract][Full Text] [Related]
15. A panel of novel biomarkers representing different disease pathways improves prediction of renal function decline in type 2 diabetes.
Pena MJ; Heinzel A; Heinze G; Alkhalaf A; Bakker SJ; Nguyen TQ; Goldschmeding R; Bilo HJ; Perco P; Mayer B; de Zeeuw D; Lambers Heerspink HJ
PLoS One; 2015; 10(5):e0120995. PubMed ID: 25973922
[TBL] [Abstract][Full Text] [Related]
16. Perturbations of the anti-ageing hormone Klotho in patients with type 1 diabetes and microalbuminuria.
Maltese G; Fountoulakis N; Siow RC; Gnudi L; Karalliedde J
Diabetologia; 2017 May; 60(5):911-914. PubMed ID: 28194484
[TBL] [Abstract][Full Text] [Related]
17. Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.
Araki S; Haneda M; Koya D; Sugimoto T; Isshiki K; Chin-Kanasaki M; Uzu T; Kashiwagi A
Diabetologia; 2007 Apr; 50(4):867-73. PubMed ID: 17225121
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
Isakova T; Craven TE; Lee J; Scialla JJ; Xie H; Wahl P; Marcovina SM; Byington RP; Wolf M
Clin J Am Soc Nephrol; 2015 Jan; 10(1):29-38. PubMed ID: 25343949
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-23 but not sKlotho levels are related to diastolic dysfunction in type 1 diabetic patients with early diabetic nephropathy.
Dogan B; Arikan IH; Guler D; Keles N; Isbilen B; Isman F; Oguz A
Int Urol Nephrol; 2016 Mar; 48(3):399-407. PubMed ID: 26759325
[TBL] [Abstract][Full Text] [Related]
20. Circulating α-klotho levels in CKD and relationship to progression.
Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
